| Chugai Pharmaceutical (CHGCY) |
JP |
$82.342B |
30.89 |
| Zoetis (ZTS) |
US |
$69.034B |
25.76 |
| Takeda Pharmaceutical (TAK) |
JP |
$47.411B |
9.43 |
| Daiichi Sankyo, - (DSNKY) |
JP |
$44.972B |
23.05 |
| BeOne Medicines - (ONC) |
KY |
$27.694B |
0.00 |
| Sandoz Group AG (SDZNY) |
CH |
$23.360B |
0.00 |
| Merck (MKKGY) |
DE |
$16.226B |
11.89 |
| Summit Therapeutics (SMMT) |
US |
$14.972B |
0.00 |
| Shionogi (SGIOY) |
JP |
$14.581B |
14.61 |
| United Therapeutics (UTHR) |
US |
$13.159B |
11.64 |
| Neurocrine Biosciences (NBIX) |
US |
$12.599B |
43.16 |
| Orion OYJ (ORINY) |
FI |
$10.006B |
27.06 |
| IPSEN (IPSEY) |
FR |
$9.836B |
0.00 |
| Corcept Therapeutics (CORT) |
US |
$7.555B |
61.41 |
| Stevanato Group S.p.A (STVN) |
IT |
$7.193B |
43.98 |
| Madrigal Pharmaceuticals (MDGL) |
US |
$6.277B |
0.00 |
| Hikma Pharmaceuticals Plc (HKMPF) |
GB |
$6.153B |
0.00 |
| Grifols, S.A (GRFS) |
ES |
$5.982B |
0.00 |
| Ionis Pharmaceuticals (IONS) |
US |
$5.890B |
0.00 |
| Ono Pharmaceutical (OPHLF) |
JP |
$5.031B |
15.30 |
| Soleno Therapeutics (SLNO) |
US |
$4.000B |
0.00 |
| Hypermarcas (HYPMY) |
BR |
$3.132B |
20.60 |
| Crinetics Pharmaceuticals (CRNX) |
US |
$2.856B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
US |
$2.782B |
9.75 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$2.489B |
13.46 |
| BioCryst Pharmaceuticals (BCRX) |
US |
$2.084B |
0.00 |
| Recursion Pharmaceuticals (RXRX) |
US |
$2.077B |
0.00 |
| NewAmsterdam Pharma (NAMS) |
NL |
$2.043B |
0.00 |
| Indivior (INDV) |
US |
$1.917B |
8.13 |
| Centessa Pharmaceuticals (CNTA) |
GB |
$1.693B |
0.00 |
| Endo (NDOI) |
US |
$1.618B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
US |
$1.563B |
0.00 |
| Evotec AG (EVO) |
DE |
$1.410B |
0.00 |
| Ocular Therapeutix (OCUL) |
US |
$1.327B |
0.00 |
| Guardian Pharmacy Services (GRDN) |
US |
$1.245B |
0.00 |
| Dyne Therapeutics (DYN) |
US |
$1.225B |
0.00 |
| Harrow (HROW) |
US |
$1.156B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
CA |
$1.070B |
21.41 |
| Enliven Therapeutics (ELVN) |
US |
$1.058B |
0.00 |
| Verve Therapeutics (VERV) |
US |
$0.991B |
0.00 |
| Collegium Pharmaceutical (COLL) |
US |
$0.951B |
5.13 |
| Akebia Therapeutics (AKBA) |
United States |
$0.935B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
IE |
$0.902B |
0.00 |
| Ardelyx (ARDX) |
US |
$0.864B |
0.00 |
| Cronos Group (CRON) |
CA |
$0.737B |
0.00 |
| Xeris Biopharma Holdings (XERS) |
US |
$0.716B |
0.00 |
| Elite Pharmaceuticals (ELTP) |
US |
$0.716B |
0.00 |
| KalVista Pharmaceuticals (KALV) |
US |
$0.612B |
0.00 |
| Xencor (XNCR) |
US |
$0.595B |
0.00 |
| Relay Therapeutics (RLAY) |
US |
$0.576B |
0.00 |
| Regulus Therapeutics (RGLS) |
US |
$0.568B |
0.00 |
| USANA Health Sciences (USNA) |
US |
$0.567B |
12.32 |
| Altimmune (ALT) |
United States |
$0.550B |
0.00 |
| Theravance Biopharma (TBPH) |
US |
$0.531B |
0.00 |
| Bioventus (BVS) |
US |
$0.528B |
13.40 |
| AleAnna (ANNA) |
US |
$0.520B |
0.00 |
| Zevra Therapeutics (ZVRA) |
US |
$0.496B |
0.00 |
| Siga Technologies (SIGA) |
US |
$0.459B |
9.58 |
| Amylyx Pharmaceuticals (AMLX) |
United States |
$0.455B |
0.00 |
| Oruka Therapeutics (ORKA) |
US |
$0.449B |
0.00 |
| Tourmaline Bio (TRML) |
US |
$0.432B |
0.00 |
| Organogenesis (ORGO) |
US |
$0.415B |
0.00 |
| Savara (SVRA) |
US |
$0.358B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
US |
$0.346B |
9.35 |
| Aquestive Therapeutics (AQST) |
US |
$0.338B |
0.00 |
| Liminatus Pharma (LIMN) |
US |
$0.333B |
0.00 |
| Heron Therapeutics (HRTX) |
US |
$0.305B |
0.00 |
| Nature's Sunshine Products (NATR) |
US |
$0.270B |
24.83 |
| Tonix Pharmaceuticals Holding (TNXP) |
US |
$0.253B |
0.00 |
| Esperion Therapeutics (ESPR) |
US |
$0.218B |
0.00 |
| MediWound (MDWD) |
IL |
$0.210B |
0.00 |
| Galectin Therapeutics (GALT) |
US |
$0.208B |
0.00 |
| ProKidney (PROK) |
US |
$0.204B |
0.00 |
| Profound Medical (PROF) |
CA |
$0.203B |
0.00 |
| OmniAb (OABI) |
US |
$0.202B |
0.00 |
| Aldeyra Therapeutics (ALDX) |
United States |
$0.190B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
US |
$0.189B |
0.00 |
| Larimar Therapeutics (LRMR) |
US |
$0.175B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
US |
$0.155B |
0.00 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.154B |
0.00 |
| Journey Medical (DERM) |
US |
$0.148B |
0.00 |
| Innate Pharma SA (IPHYF) |
FR |
$0.145B |
0.00 |
| Lyell Immunopharma (LYEL) |
US |
$0.142B |
0.00 |
| Lexeo Therapeutics (LXEO) |
US |
$0.141B |
0.00 |
| VAXART, INC (VXRT) |
US |
$0.140B |
0.00 |
| Avita Medical (RCEL) |
US |
$0.139B |
0.00 |
| Inhibikase Therapeutics (IKT) |
US |
$0.126B |
0.00 |
| Korro Bio (KRRO) |
US |
$0.117B |
0.00 |
| Champions Oncology (CSBR) |
US |
$0.116B |
19.09 |
| Protara Therapeutics (TARA) |
US |
$0.115B |
0.00 |
| Ironwood Pharmaceuticals (IRWD) |
US |
$0.113B |
0.00 |
| Cardiol Therapeutics (CRDL) |
CA |
$0.109B |
0.00 |
| Achieve Life Sciences (ACHV) |
Canada |
$0.109B |
0.00 |
| Nektar Therapeutics (NKTR) |
US |
$0.107B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
US |
$0.102B |
0.00 |
| Cassava Sciences (SAVA) |
US |
$0.100B |
0.00 |
| Fractyl Health (GUTS) |
US |
$0.094B |
0.00 |
| Dominari Holdings (DOMH) |
US |
$0.092B |
0.00 |
| Wellgistics Health (WGRX) |
US |
$0.088B |
0.00 |
| Nutriband (NTRB) |
US |
$0.087B |
0.00 |
| Surrozen (SRZN) |
US |
$0.085B |
0.00 |
| Unicycive Therapeutics (UNCY) |
US |
$0.084B |
0.00 |
| Arch Biopartners (ACHFF) |
Canada |
$0.084B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
US |
$0.080B |
59.56 |
| ESSA Pharma (EPIX) |
CA |
$0.075B |
0.00 |
| Inotiv (NOTV) |
US |
$0.075B |
0.00 |
| Pyxis Oncology (PYXS) |
US |
$0.071B |
0.00 |
| Vivani Medical (VANI) |
US |
$0.068B |
0.00 |
| Assertio Holdings (ASRT) |
US |
$0.063B |
0.00 |
| Allergy Therapeutics (AGYTF) |
United Kingdom |
$0.059B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
US |
$0.057B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
US |
$0.056B |
0.00 |
| Metagenomi (MGX) |
US |
$0.055B |
0.00 |
| Rafael Holdings (RFL) |
US |
$0.055B |
0.00 |
| Gain Therapeutics (GANX) |
US |
$0.054B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
US |
$0.054B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
US |
$0.052B |
0.00 |
| Avalo Therapeutics (AVTX) |
US |
$0.052B |
0.00 |
| Context Therapeutics (CNTX) |
US |
$0.051B |
0.00 |
| Century Therapeutics (IPSC) |
US |
$0.051B |
0.00 |
| Klotho Neurosciences (KLTO) |
US |
$0.049B |
0.00 |
| Prelude Therapeutics (PRLD) |
US |
$0.049B |
0.00 |
| Mural Oncology (MURA) |
IE |
$0.043B |
0.00 |
| Jupiter Neurosciences (JUNS) |
US |
$0.041B |
0.00 |
| Iterum Therapeutics (ITRM) |
IE |
$0.040B |
0.00 |
| ElectroCore (ECOR) |
US |
$0.039B |
0.00 |
| Acrivon Therapeutics (ACRV) |
United States |
$0.039B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
US |
$0.038B |
0.00 |
| PolyPid (PYPD) |
IL |
$0.034B |
0.00 |
| Reviva Pharmaceuticals Holdings (RVPH) |
US |
$0.032B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
CN |
$0.030B |
0.00 |
| SCYNEXIS (SCYX) |
US |
$0.029B |
0.00 |
| Tempest Therapeutics (TPST) |
US |
$0.025B |
0.00 |
| Enlivex Therapeutics (ENLV) |
IL |
$0.025B |
0.00 |
| Relmada Therapeutics (RLMD) |
US |
$0.023B |
0.00 |
| Natural Alternatives (NAII) |
US |
$0.021B |
0.00 |
| Carisma Therapeutics (CARM) |
US |
$0.021B |
0.00 |
| FibroGen (FGEN) |
US |
$0.021B |
0.00 |
| DURECT (DRRX) |
US |
$0.020B |
0.00 |
| BioVie (BIVI) |
US |
$0.020B |
0.00 |
| BioLineRx (BLRX) |
IL |
$0.019B |
0.00 |
| Ernexa Therapeutics (ERNA) |
US |
$0.019B |
0.00 |
| Lipocine (LPCN) |
US |
$0.017B |
0.00 |
| CASI Pharmaceuticals (CASI) |
CN |
$0.017B |
0.00 |
| Mannatech (MTEX) |
US |
$0.017B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
US |
$0.017B |
0.00 |
| ProPhase Labs (PRPH) |
US |
$0.015B |
0.00 |
| Vivos Therapeutics (VVOS) |
US |
$0.015B |
0.00 |
| VYNE Therapeutics (VYNE) |
US |
$0.014B |
0.00 |
| Lyra Therapeutics (LYRA) |
US |
$0.014B |
0.00 |
| Scienture Holdings (SCNX) |
US |
$0.013B |
0.00 |
| Minerva Neurosciences (NERV) |
US |
$0.013B |
2.21 |
| TherapeuticsMD (TXMD) |
US |
$0.013B |
0.00 |
| Cosmos Health (COSM) |
US |
$0.012B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
US |
$0.011B |
0.00 |
| Ainos (AIMD) |
United States |
$0.011B |
0.00 |
| Mangoceuticals (MGRX) |
US |
$0.010B |
0.00 |
| Talphera (TLPH) |
US |
$0.010B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
US |
$0.010B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
US |
$0.009B |
0.00 |
| Traws Pharma (TRAW) |
US |
$0.009B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.009B |
0.00 |
| NLS Pharmaceutics (NLSP) |
CH |
$0.008B |
0.00 |
| Biomerica (BMRA) |
US |
$0.008B |
0.00 |
| Nuvilex (PMCB) |
US |
$0.007B |
0.00 |
| SHINECO (SISI) |
CN |
$0.007B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
IL |
$0.007B |
0.00 |
| Incannex Healthcare (IXHL) |
AU |
$0.007B |
0.00 |
| Alaunos Therapeutics (TCRT) |
US |
$0.007B |
0.00 |
| TransCode Therapeutics (RNAZ) |
US |
$0.006B |
0.00 |
| Aptorum Group (APM) |
GB |
$0.006B |
0.00 |
| Indaptus Therapeutics (INDP) |
US |
$0.005B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
US |
$0.005B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
US |
$0.005B |
0.00 |
| CERo Therapeutics Holdings (CERO) |
US |
$0.004B |
0.00 |
| Xenetic Biosciences (XBIO) |
US |
$0.004B |
0.00 |
| Redhill Biopharma (RDHL) |
IL |
$0.004B |
0.00 |
| Clearmind Medicine (CMND) |
CA |
$0.004B |
0.00 |
| Plus Therapeutics (PSTV) |
US |
$0.003B |
0.00 |
| PainReform (PRFX) |
IL |
$0.003B |
0.00 |
| SciSparc (SPRC) |
IL |
$0.003B |
0.00 |
| XORTX Therapeutics (XRTX) |
CA |
$0.003B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
US |
$0.003B |
0.00 |
| InMed Pharmaceuticals (INM) |
CA |
$0.003B |
0.00 |
| Aditxt (ADTX) |
United States |
$0.003B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
IL |
$0.003B |
0.00 |
| Heatwurx (PCSA) |
US |
$0.003B |
0.00 |
| Jaguar Animal Health (JAGX) |
US |
$0.003B |
0.00 |
| Qualigen Therapeutics (QLGN) |
US |
$0.003B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
US |
$0.002B |
0.00 |
| TNF Pharmaceuticals (TNFA) |
US |
$0.002B |
0.00 |
| Conduit Pharmaceuticals (CDT) |
US |
$0.002B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
US |
$0.002B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
CN |
$0.000B |
0.00 |
| 4D Pharma (LBPS) |
GB |
$0.000B |
0.00 |
| MEI Pharma (MEIP) |
US |
$0.000B |
0.00 |
| Patheon (PTHN) |
NL |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
US |
$0.000B |
0.00 |
| Silence Therapeutics (SLN) |
GB |
$0.000B |
0.00 |
